Dr Reddy's Laboratories Limited today announced that it has completed the acquisition of select divisions of Wockhardt Limited's branded generics business in India and a few other international territories of
Under the new terms, an amount of Rs 1,483 crore would be paid on the date of closing.
First Published: Jun 10 2020 | 5:22 PM IST
Key stories on business-standard.com are available only to BS Premium subscribers.
Register to read more on Business-Standard.com